Analyst Comments
Provided by:
Set Up E-mail Alerts For Analyst Comments »
The top source for Wall Street analyst comments, price target and estimate changes, and speculation.
This page tracks and reports on important analyst comments in real-time. Upgrade to StreetInsider.com Premium to get a daily listing of 'Hot Comments,' or the best daily comments as we see them. Premium members can also receive e-mail/mobile alerts on important dividend events. 2-Week Free Trial available.
This page tracks and reports on important analyst comments in real-time. Upgrade to StreetInsider.com Premium to get a daily listing of 'Hot Comments,' or the best daily comments as we see them. Premium members can also receive e-mail/mobile alerts on important dividend events. 2-Week Free Trial available.
-
Goldman Sachs Starts GlaxoSmithKline (GSK:LN) (GSK) at Neutral
-
Goldman Sachs Starts AstraZeneca (AZN:LN) (AZN) at Buy
-
Jefferies Downgrades Wharf REIC (1997:HK) (WRFRF) to Hold
-
-
-
-
-
-
-
Stifel Upgrades International Game Tech (IGT) to Buy
-
-
-
-
-
-
-
NMDC Ltd (NMDC:IN) PT Raised to INR170 at BofA Securities
-
-
-
-
-
-
-
SJVN Ltd (SJVN:IN) PT Raised to INR75 at Goldman Sachs
-
-
-
-
-
-
-
Citi Reiterates Sell Rating on Samvardhana Motherson International (MOTHERSO:IN)
-
-
-
-
-
-
-
NMDC Ltd (NMDC:IN) PT Raised to INR210 at JPMorgan
-
-
-
-
-
-
-
Brookline Capital Markets Starts Forte Biosciences Inc. (FBRX) at Buy
-
-
-
-
-
358,985 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving Analyst Comments reports.